TEST SCHEDULES
Cellular
Flow Cytometry
Immunohistochemistry
Sub Cellular
Classic Cytogenetics
Digital Image Analysis
Sub Chromosomal
Molecular Cytogenetics FISH
Molecular
Molecular Genetics- PCR
New classification of leukemias criteria rely strongly on the identification of molecular aberrations inherent in particular subtypes. Recurring molecular abnormalities are targets of new therapeutics (ie Gleevec, ATRA ). Diagnosis, prognosis, and monitoring for residual disease are the focus of our clinical repertoire for all leukemias.
New classification of leukemias criteria rely strongly on the identification of molecular aberrations inherent in particular subtypes.
Recurring molecular abnormalities are targets of new therapeutics (ie Gleevec, ATRA ).
Diagnosis, prognosis, and monitoring for residual disease are the focus of our clinical repertoire for all leukemias.
TESTS BY DISEASE
Lymphoma
Lung Cancer
Myelodysplasia
Myeloma
Prenatal Diagnosis
Prostate Cancer
TEST SCHEDULES
TESTS 
